Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Subthreshold Peanut in Infants
NCT04761835Phase 2Withdrawn
- Sponsor
- Johns Hopkins University
- Start
- Nov 2021
- Primary completion
- Nov 2026
- Modality
- Recombinant Proteins and Enzymes, Allergy Immunotherapy
01
Overview
A Phase 2 trial of peanut protein in peanut allergy, sponsored by Johns Hopkins University. Planned start Nov 2021; status: withdrawn.
02
Drugs
peanut protein
03
Conditions
peanut allergy
Beyond the preview
Go deeper on NCT04761835.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04761835.